Skip to main content
. 2023 Nov 22;10(1):184–195. doi: 10.1021/acsinfecdis.3c00480

Figure 1.

Figure 1

Phenotypes of clinically isolated CSAB and CRAB. (A) Minimal inhibitory concentration (MIC) of clinically isolated A. baumannii to Meropenem. (B) Growth curves of CSAB and CRAB. (C) Survival capability of CSAB and CRAB under the indicated concentration of Meropenem (8 μg/mL). (D) Carbapenemase was detected using the CarbAcineto NP method. Results are displayed as means ± SD. Significant differences are identified **P < 0.01.